9 August 2012 – BioProcessing Solutions Webinar
Optimizing the Bioprocessing of Future Research Samples: A Focus on Integrity, Quality and Control
Thursday, 9 August 2012 11:30AM ET
Research samples are invaluable scientific assets that are foundational to drug discovery and development. With sample collection and relevant data associated with those samples on the rise, it is imperative that precious research samples are valued as quality renewable resources and are optimized for current research and protected for future research. By developing an understanding of industry standards and best practices for sample lifecycle management and the role of sample bioprocessing within this process, a research organization can be better positioned to reduce research costs, improve efficiencies, create revenue streams and decrease time to discovery.
This in-depth webinar will focus on evolving bioprocessing sample management solutions and will highlight:
- The important steps involved in sample lifecycle management
- The critical need to develop and understand industry SOPs and best practices in sample management focusing on integrity, quality and control
- What is the advantage of integrated bioprocessing and how can it be leveraged to optimize the current and future value of each sample asset to support future research
- The importance of understanding and establishing sample collection and bioprocessing guidelines in order to ensure the future value of a sample
- Case studiesdemonstrating the value of bioprocessing solutions in supporting sample preparation, preservation, and improved utilization for future research.
RUCDR Infinite Biologics: a global leader in the bioprocessing and biobanking of samples for genetic, gene and cell-based research and BioStorage Technologies, Inc. the leading global provider of comprehensive sample management solutions has developed a strategic and innovative Bioprocessing Solutions Alliance which provides to the bioscience industry an integrated, state-of-the-art scientific approach and technology infrastructure to the delivery of advanced sample bioprocessing and biobanking solutions.
BioStorage Technologies, Inc.: is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering flexible onsite, offsite and hybrid sample outsourcing models for the management of research assets, BioStorage Technologies manages the complete life-cycle of samples. With an expert team of global sample consultants, industry-leading temperature-controlled storage facilities, and state-of-the-art virtual sample management solutions, the company supports its customers in maximizing opportunities, minimizing risk and reducing costs.
Dr. Andrew Brooks, Chief Operating Officer, RUCDR Infinite Biologics
Dr. Brooks is currently the Chief Operating Officer of the Rutgers University Cell and DNA Repository (RUCDR) and Director of the Bionomics Research and Technology Center (BRTC) at the Environmental and Occupational Health Science Institute of the University of Medicine and Dentistry of New Jersey. He is an Associate Professor of Environmental Medicine and Genetics at UMDNJ/Rutgers. Dr. Brooks is a molecular neuroscientist whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. These studies investigate gene-environment interactions in the context of aging, neurodegenerative disease and neurotoxicant exposure. Dr. Brooks is a well-recognized genomicist and has been involved in the development and implementation of cutting edge molecular based technologies for nucleic acid and protein analyses. He has worked to automate the RUCDR and build the service entity that provides high throughput sample management and analysis for DNA, RNA and protein-based technologies to hundreds of labs globally.
R. Aleks Davis, Associate Director of Comprehensive Solutions and Scientific Advisor, BioStorage Technologies, Inc.
As Associate Director and Scientific Advisor of Comprehensive Solutions at BioStorage Technologies, Davis is the supervisor of onsite biorepository operations and responsible for oversight of multiple biorepository facilities, strategic consulting services, and providing scientific oversight for sample processing services.
Prior to joining BioStorage Technologies, Davis was the Program Manager of Tailored Therapeutics at Eli Lilly and Company where he lead biomarker development projects and managed the company’s biospecimen bank. He has over 12 years of experience in managing laboratory and sample management operations within the pharmaceutical industry for Eli Lilly, serving as a synthetic chemist in the isotopic chemistry group and manager of their biomarker and immunogenicity assay development area.
Davis holds a B.S. in Chemistry from Georgia Southern University and is ACS certified with an emphasis in organic chemistry. He is a member of ISBER, ACS, member and chair of the AAPS Biomarker Program Committee, and is licensed by the NRC.